This work has been financed by the ERDF project number 2010/0231/2DP/2.1.1.1.0/10/APIA/VIAA/044.
The authors thank Dr. Thomas Wex and Prof. Peter Malfertheiner from Otto-von-Guericke University Magdeburg, Clinic of Gastroenterology, Hepatology and Infectious Diseases for clinical samples.
1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin (2011) 61(2): 69-90.
2. Zhong L, Coe SP, Stromberg AJ, Khattar NH, Jett JR, Hirschowitz EA. Profiling tumor-associated antibodies for early detection of non-small cell lung cancer. J Thorac Oncol (2006) 1: 513-9
3. Tan HT, Low J, Lim SG, Chung MC. Serum autoantibodies as biomarkers for early cancer detection. FEBS J (2009) 276(23): 6880-904.
4. Kalnina Z, Silina K, Line A. Autoantibody profiles as biomarkers for response to therapy and early detection of cancer. Current Cancer Therapy Reviews (2008) 4(2): 149-56.
5. Chapman CJ, Healey GF, Murray A, Boyle P, Robertson C, Peek LJ, Allen J, Thorpe AJ, Hamilton-Fairley G, Parsy-Kowalska CB, MacDonald IK, Jewell W, Maddison P, Robertson JF. EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays. Tumour Biol (2012) 33(5): 1319-26
6. Kalnina Z, Silina K, Meistere I, Zayakin P, Rivosh A, Abols A, Leja M, Minenkova O, Schadendorf D, Line A. Evaluation of T7 and lambda phage display systems for survey of autoantibody profiles in cancer patients. J Immunol Methods (2008) 334(1-2): 37-50.
7. Zayakin P, Ancans G, Silina K, Meistere I, Kalnina Z, Andrejeva D, Endzelins E, Ivanova L, Pismennaja A, Ruskule A, Donina S, Wex T, Malfertheiner P, Leja M, Line A. Tumour-associated autoantibody signature for the early detection of gastric cancer. Int J Cancer (2013) 132(1): 137-47.
8. Hishida A, Matsuo K, Goto Y, Hamajima N. Genetic predisposition to Helicobacter pylori-induced gastric precancerous conditions. World J Gastrointest Oncol (2010) 2(10): 369-79.